Fig. 5From: Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malariaDay 28 PCR-adjusted ACPR and crude ACPR. PP populationBack to article page